Zyban tablet
Pursuant to Teva’s existing strategic alliance agreement with IMPAX, Teva has U. Forward-looking statements speak only as to the date on which they are made, and Impax undertakes no obligation to update publicly or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise. Business Editors/Health/Medical Writers FORT Zyban tablet lauderdale, Fla. –(BUSINESS WIRE)–July 31, 2003 Andrx Corporation (Nasdaq:ADRX) (Andrx or the Company) announced today that it has entered into an Exclusivity Transfer Agreement with Impax Corporation (Nasdaq:IPXL) and a subsidiary of Teva Pharmaceutical Industries Ltd. Marketing rights to IMPAX’s versions of these products. The first, Wellbutrin SR(R), is a zyban tablet buproprion hydrochloride extended-release tablet marketed by Glaxo Wellcome, Inc. People in the trials had been smoking on average for 20 years, and a quarter of them smoked up to 60 cigarettes a day. Safe Harbor Statement zyban tablet under the U. The Committee on Safety of Medicines (CSM) said yesterday that changes were being made to the way Zyban was prescribed and doctors would be given strengthened warnings. Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA filings and approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, the regulatory environment, fluctuations in operating results and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission. AN ANTI-SMOKING drug is to be controlled more strictly after reports that 37 British patients have died and more than 5,000 have suffered bad reactions while taking the tablets. Under the Exclusivity Transfer Agreement, Andrx will continue to seek approval of its ANDAs. Sales of Zyban tablet approximately $1. 6 billion for zyban tablet the twelve-month period ending March 31, 2003 according to IMS. Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this news release contain information that is not historical, these statements are forward-looking in nature and express the beliefs and expectations of management. We continue to work with our partners to bring these important products to the market. IMPAX announced yesterday that the U. The parties believe that the Andrx ANDAs for the products are entitled, under the Hatch-Waxman Act, to a 180-day period of marketing exclusivity. Annual sales of brand and generic Zyban(R) were US$ 12 million for the 12 months ending December 2007 according to IMS zyban tablet health data. Warnings to doctors about the risk of seizures will emphasise that Zyban should not be used in vulnerable patients unless there are compelling clinical reasons. In its ANDA program, zyban tablet the Company is developing generic versions of selected high sales volume controlled-release brand name pharmaceuticals. The patents listed for Wellbutrin Zyban tablet sr and Zyban relate to the method of formulating these products. The therapy is said to be three times more effective than the anti- smoking drug Zyban, which is due to be launched on prescription in the UK next year. Annual sales of brand and generic Wellbutrin SR(R) were US$ 498 million for the 12 zyban tablet months ending December 2007 according to IMS Health data.
